Thomas Smith
Stock Analyst at Leerink Partners
(4.98)
# 64
Out of 4,988 analysts
688
Total ratings
55.6%
Success rate
50.2%
Average return
Main Sectors:
Stocks Rated by Thomas Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVMN Evommune | Rated: Buy | $52 → $22 | $9.65 | +127.98% | 3 | Sep 10, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $100 | $69.53 | +43.82% | 28 | Sep 10, 2026 | |
| SYRE Spyre Therapeutics | Rated: Buy | $106 → $128 | $90.25 | +41.83% | 2 | Sep 10, 2026 | |
| KROS Keros Therapeutics | Reiterated: Buy | $35 → $23 | $11.19 | +105.54% | 53 | Aug 4, 2026 | |
| ALT Altimmune | Reiterated: Buy | $10 | $3.25 | +207.69% | 2 | Jul 28, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $780 → $1,065 | $990.32 | +7.54% | 36 | Jul 24, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $70 | $38.24 | +83.05% | 41 | Jul 22, 2026 | |
| AVTX Avalo Therapeutics | Initiated Coverage: Buy | $38 | $16.57 | +129.33% | 1 | Jul 6, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $14.05 | - | 8 | Jun 12, 2026 | |
| XFOR X4 Pharmaceuticals | Initiated Coverage: Buy | $12 | $3.58 | +235.20% | 1 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $1.92 | +212.50% | 34 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.03 | - | 17 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $7.77 | +311.84% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $22.00 | +127.27% | 39 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $50 | $36.95 | +35.32% | 37 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $12.17 | +195.81% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.28 | - | 20 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.78 | +217.46% | 1 | Jan 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $32 | $7.13 | +348.81% | 18 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 102.00 | kr 36.62 | +178.54% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $28.99 | +307.04% | 38 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.51 | - | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.50 | +27.27% | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $115 | $105.04 | +9.48% | 17 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $14 | $12.39 | +12.99% | 32 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $531.52 | n/a | 39 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $11.09 | n/a | 15 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.62 | n/a | 34 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.54 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $16.00 | n/a | 16 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $10.62 | n/a | 28 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $14.95 | n/a | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 | $117.75 | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.54 | n/a | 25 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $1.11 | n/a | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.32 | n/a | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2 | $22.59 | n/a | 16 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 5,179p | 123p | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $21 | $9.60 | n/a | 1 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $6 | $2.19 | n/a | 1 | Sep 8, 2017 |
Evommune
Sep 10, 2026
Rated: Buy
Price Target: $52 → $22
Current: $9.65
Upside: +127.98%
Disc Medicine
Sep 10, 2026
Reiterated: Buy
Price Target: $100
Current: $69.53
Upside: +43.82%
Spyre Therapeutics
Sep 10, 2026
Rated: Buy
Price Target: $106 → $128
Current: $90.25
Upside: +41.83%
Keros Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $35 → $23
Current: $11.19
Upside: +105.54%
Altimmune
Jul 28, 2026
Reiterated: Buy
Price Target: $10
Current: $3.25
Upside: +207.69%
argenx SE
Jul 24, 2026
Reiterated: Buy
Price Target: $780 → $1,065
Current: $990.32
Upside: +7.54%
Celldex Therapeutics
Jul 22, 2026
Reiterated: Buy
Price Target: $70
Current: $38.24
Upside: +83.05%
Avalo Therapeutics
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $16.57
Upside: +129.33%
Climb Bio
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.05
Upside: -
X4 Pharmaceuticals
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.58
Upside: +235.20%
May 28, 2026
Upgraded: Buy
Price Target: $6
Current: $1.92
Upside: +212.50%
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.03
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $7.77
Upside: +311.84%
Apr 6, 2026
Reiterated: Buy
Price Target: $50
Current: $22.00
Upside: +127.27%
Apr 2, 2026
Reiterated: Buy
Price Target: $52 → $50
Current: $36.95
Upside: +35.32%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $12.17
Upside: +195.81%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.28
Upside: -
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.78
Upside: +217.46%
Dec 15, 2025
Reiterated: Buy
Price Target: $25 → $32
Current: $7.13
Upside: +348.81%
Nov 26, 2025
Initiated Coverage: Buy
Price Target: kr 102.00
Current: kr 36.62
Upside: +178.54%
Oct 23, 2025
Reiterated: Buy
Price Target: $118
Current: $28.99
Upside: +307.04%
Oct 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.51
Upside: -
Oct 15, 2025
Reiterated: Buy
Price Target: $7
Current: $5.50
Upside: +27.27%
Oct 8, 2025
Reiterated: Buy
Price Target: $104 → $115
Current: $105.04
Upside: +9.48%
Oct 1, 2025
Reiterated: Buy
Price Target: $73 → $14
Current: $12.39
Upside: +12.99%
Aug 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $531.52
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $26
Current: $11.09
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $8
Current: $2.62
Upside: n/a
Apr 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.54
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $58
Current: $16.00
Upside: n/a
Aug 8, 2024
Reiterated: Hold
Price Target: $5
Current: $10.62
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $6
Current: $14.95
Upside: n/a
Aug 7, 2024
Reiterated: Hold
Price Target: $33
Current: $117.75
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $7
Current: $3.54
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $46
Current: $1.11
Upside: n/a
Mar 15, 2024
Reiterated: Buy
Price Target: n/a
Current: $20.32
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: $13 → $2
Current: $22.59
Upside: n/a
Aug 8, 2022
Reiterated: Buy
Price Target: 5,179p
Current: 123p
Upside: n/a
Jan 17, 2019
Initiated Coverage: Hold
Price Target: $21
Current: $9.60
Upside: n/a
Sep 8, 2017
Initiated Coverage: Hold
Price Target: $6
Current: $2.19
Upside: n/a